Publications by authors named "Tali Feferman"

Claim this Profile
M
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Oren Barboy, Akhiad Bercovich, Hanjie Li, Yaniv Eyal-Lubling, Adam Yalin, Tali Feferman

Nat Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman

Sci Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting.
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, Assaf Weiner, Noy Cohen Saban, Tali Feferman

Nat Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.
Inbal Farkash, Tali Feferman, Noy Cohen-Saban, Yahel Avraham, David Morgenstern

Cell Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
Victoria Indenbaum, Ravit Koren, Shiri Katz-Likvornik, Mayan Yitzchaki, Osnat Halpern, Tali Feferman

PLoS One· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Rina Aharoni, Raya Eilam, Nofar Schottlender, Lihi Radomir, Sandra Leistner-Segal, Tali Feferman

J Neuroimmunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced CTL motility and activity in avascular tumor areas.
Yoav Manaster, Zohar Shipony, Anat Hutzler, Masha Kolesnikov, Camila Avivi, Tali Feferman

Cancer Immunol Immunother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
Shelly Kalaora, Yochai Wolf, Tali Feferman, Eilon Barnea, Erez Greenstein

Cancer Discov· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bone marrow is patrolled by NK cells that are primed and expand in response to systemic viral activation.
Idan Milo, Ronnie Blecher-Gonen, Zohar Barnett-Itzhaki, Raz Bar-Ziv, Orna Tal, Tali Feferman

Eur J Immunol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Injury Repair by Transplantation of Adult Lung Cells Following Preconditioning of Recipient Mice.
Irit Milman Krentsis, Chava Rosen, Elias Shezen, Anna Aronovich, Bar Nathanson, Tali Feferman

Stem Cells Transl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active dissemination of cellular antigens by DCs facilitates CD8 T-cell priming in lymph nodes.
Irina Gurevich, Tali Feferman, Idan Milo, Orna Tal, Ofra Golani

Eur J Immunol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.
Yael Gropper, Tali Feferman, Tali Shalit, Tomer-Meir Salame, Ziv Porat

Cell Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis.
Marie Maurer, Sylvain Bougoin, Tali Feferman, Mélinée Frenkian, Jacky Bismuth

Acta Neuropathol Commun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Miriam C Souroujon, Revital Aricha, Tali Feferman, Keren Mizrachi, Debby Reuveni

Ann N Y Acad Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Revital Aricha, Tali Feferman, Sonia Berrih-Aknin, Sara Fuchs, Miriam C Souroujon

Ann N Y Acad Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
Revital Aricha, Tali Feferman, Hamish S Scott, Miriam C Souroujon, Sonia Berrih-Aknin

J Autoimmun· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of phosphodiesterases in autoimmune diseases.
Keren Mizrachi, Revital Aricha, Tali Feferman, Neta Kela-Madar, Ilana Mandel

J Neuroimmunol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
Tali Feferman, Revital Aricha, Keren Mizrachi, Erez Geron, Ronen Alon

J Neuroimmunol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Sara Fuchs, Tali Feferman, Roberto Meidler, Raanan Margalit, Camille Sicsic

Ann N Y Acad Sci· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Renuka T R Menon, Tali Feferman, Revital Aricha, Miriam C Souroujon, Sara Fuchs

J Neuroimmunol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Sara Fuchs, Tali Feferman, Roberto Meidler, Raanan Margalit, Camille Sicsic

J Neuroimmunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
Revital Aricha, Tali Feferman, Sara Fuchs, Miriam C Souroujon

J Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
Sara Fuchs, Tali Feferman, Roberto Meidler, Talma Brenner, Orgad Laub

Isr Med Assoc J· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
Sara Fuchs, Tali Feferman, Kai-Yun Zhu, Roberto Meidler, Raanan Margalit

Ann N Y Acad Sci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray in search of new drug targets for myasthenia gravis.
Tali Feferman, Revital Aricha, Renuka Menon, Miriam C Souroujon, Sonia Berrih-Aknin

Ann N Y Acad Sci· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis